Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bio-Rad Laboratories, Inc. stock logo
BIO.B
Bio-Rad Laboratories
$365.08
$359.35
$244.54
▼
$365.08
$9.76B0.9615 shs4 shs
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$609.89
-1.6%
$604.41
$373.00
▼
$677.90
$17.31B1.18261,501 shs155,251 shs
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
$1,597.59
+2.2%
$1,430.36
$1,023.05
▼
$1,604.39
$31.32B1.19225,329 shs245,320 shs
Revvity Inc. stock logo
RVTY
Revvity
$155.08
-0.3%
$134.17
$81.22
▼
$166.25
$17.36B1.062.32 million shs1.39 million shs
7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bio-Rad Laboratories, Inc. stock logo
BIO.B
Bio-Rad Laboratories
0.00%0.00%0.00%+18.01%+28.15%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
+1.31%-0.07%+5.54%+15.64%+23.71%
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
+0.80%+1.39%+20.84%+18.84%+22.69%
Revvity Inc. stock logo
RVTY
Revvity
+1.01%-0.87%+25.15%+40.03%+76.28%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bio-Rad Laboratories, Inc. stock logo
BIO.B
Bio-Rad Laboratories
$365.08
$359.35
$244.54
▼
$365.08
$9.76B0.9615 shs4 shs
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$609.89
-1.6%
$604.41
$373.00
▼
$677.90
$17.31B1.18261,501 shs155,251 shs
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
$1,597.59
+2.2%
$1,430.36
$1,023.05
▼
$1,604.39
$31.32B1.19225,329 shs245,320 shs
Revvity Inc. stock logo
RVTY
Revvity
$155.08
-0.3%
$134.17
$81.22
▼
$166.25
$17.36B1.062.32 million shs1.39 million shs
7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bio-Rad Laboratories, Inc. stock logo
BIO.B
Bio-Rad Laboratories
0.00%0.00%0.00%+18.01%+28.15%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
+1.31%-0.07%+5.54%+15.64%+23.71%
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
+0.80%+1.39%+20.84%+18.84%+22.69%
Revvity Inc. stock logo
RVTY
Revvity
+1.01%-0.87%+25.15%+40.03%+76.28%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bio-Rad Laboratories, Inc. stock logo
BIO.B
Bio-Rad Laboratories
0.00
N/AN/AN/A
Medpace Holdings, Inc. stock logo
MEDP
Medpace
2.23
Hold$607.73-0.35% Downside
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
2.27
Hold$1,469.15-8.04% Downside
Revvity Inc. stock logo
RVTY
Revvity
2.26
Hold$124.43-19.76% Downside

Current Analyst Ratings Breakdown

Latest BIO.B, MTD, RVTY, and MEDP Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/13/2026
Revvity Inc. stock logo
RVTY
Revvity
Boost Price TargetBuy$130.00 ➝ $175.00
10/13/2026
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
Boost Price TargetEqual Weight$1,450.00 ➝ $1,575.00
10/8/2026
Medpace Holdings, Inc. stock logo
MEDP
Medpace
UpgradeBuy (B-) ➝ Buy (B)
10/8/2026
Revvity Inc. stock logo
RVTY
Revvity
UpgradeHold (C-) ➝ Hold (C)
10/7/2026
Medpace Holdings, Inc. stock logo
MEDP
Medpace
Boost Price TargetOutperform$665.00 ➝ $700.00
10/7/2026
Revvity Inc. stock logo
RVTY
Revvity
Boost Price TargetEqual Weight$115.00 ➝ $160.00
10/7/2026
Medpace Holdings, Inc. stock logo
MEDP
Medpace
Boost Price TargetEqual Weight$600.00 ➝ $625.00
10/7/2026
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
Boost Price TargetOverweight$1,575.00 ➝ $1,700.00
10/5/2026
Revvity Inc. stock logo
RVTY
Revvity
Initiated CoverageOutperform
9/30/2026
Medpace Holdings, Inc. stock logo
MEDP
Medpace
Initiated CoverageSell ➝ Neutral$405.00 ➝ $673.00
9/30/2026
Medpace Holdings, Inc. stock logo
MEDP
Medpace
UpgradeSell ➝ Hold$405.00 ➝ $673.00
(Data available from 10/13/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bio-Rad Laboratories, Inc. stock logo
BIO.B
Bio-Rad Laboratories
$2.58B3.78$10.02 per share36.43$276.16 per share1.32
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$2.53B6.73$16.74 per share36.44$16.30 per share37.42
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
$4.03B7.95$50.73 per share31.49($1.16) per share-1,377.24
Revvity Inc. stock logo
RVTY
Revvity
$2.86B6.06$8.79 per share17.65$63.95 per share2.43
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bio-Rad Laboratories, Inc. stock logo
BIO.B
Bio-Rad Laboratories
$759.90M$8.2539.34N/AN/A8.59%3.54%2.48%N/A
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$451.12M$17.0636.3531.812.7717.67%110.15%24.84%10/21/2026 (Confirmed)
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
$869.19M$44.4334.8330.563.1521.91%-1,212.14%25.11%11/5/2026 (Estimated)
Revvity Inc. stock logo
RVTY
Revvity
$241.20M$2.1029.0926.282.838.16%8.34%5.01%11/3/2026 (Confirmed)

Latest BIO.B, MTD, RVTY, and MEDP Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/5/2026Q3 2026
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
$12.12N/AN/AN/A$1.07 billionN/A
11/3/2026Q3 2026
Revvity Inc. stock logo
RVTY
Revvity
$1.30N/AN/AN/A$694.74 millionN/A
10/21/2026Q3 2026
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$4.44N/AN/AN/A$714.47 millionN/A
8/4/2026Q2 2026
Revvity Inc. stock logo
RVTY
Revvity
$1.21$1.41+$0.20$0.47$702.96 million$729.69 million
7/31/2026Q2 2026
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
$10.78$11.46+$0.68$11.55$1.03 billion$1.03 billion
7/22/2026Q2 2026
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$3.98$4.25+$0.27$4.25$689.51 million$707.33 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Bio-Rad Laboratories, Inc. stock logo
BIO.B
Bio-Rad Laboratories
N/AN/AN/AN/AN/A
Medpace Holdings, Inc. stock logo
MEDP
Medpace
N/AN/AN/AN/AN/A
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
N/AN/AN/AN/AN/A
Revvity Inc. stock logo
RVTY
Revvity
$0.280.18%N/A13.33%N/A

Latest BIO.B, MTD, RVTY, and MEDP Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/31/2026
Revvity Inc. stock logo
RVTY
Revvity
quarterly$0.070.25%10/23/202610/23/202611/13/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bio-Rad Laboratories, Inc. stock logo
BIO.B
Bio-Rad Laboratories
0.11
3.14
2.33
Medpace Holdings, Inc. stock logo
MEDP
Medpace
N/A
0.73
0.73
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
159.45
1.12
0.78
Revvity Inc. stock logo
RVTY
Revvity
0.36
1.80
1.50

Institutional Ownership

CompanyInstitutional Ownership
Bio-Rad Laboratories, Inc. stock logo
BIO.B
Bio-Rad Laboratories
0.01%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
77.98%
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
95.07%
Revvity Inc. stock logo
RVTY
Revvity
86.65%

Insider Ownership

CompanyInsider Ownership
Bio-Rad Laboratories, Inc. stock logo
BIO.B
Bio-Rad Laboratories
28.38%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
20.50%
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
0.71%
Revvity Inc. stock logo
RVTY
Revvity
0.85%
CompanyEmployeesShares OutstandingFree FloatOptionable
Bio-Rad Laboratories, Inc. stock logo
BIO.B
Bio-Rad Laboratories
7,45026.74 million19.15 millionNot Optionable
Medpace Holdings, Inc. stock logo
MEDP
Medpace
6,20027.91 million22.19 millionOptionable
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
18,10020.04 million19.90 millionOptionable
Revvity Inc. stock logo
RVTY
Revvity
11,000111.59 million110.64 millionOptionable

Recent News About These Companies

What Does Revvity (NYSE:RVTY) New Assay Add to NYSE Composite?
Revvity earnings preview: What to expect
Revvity to Host Investor Day
Revvity (NYSE:RVTY) CAO Sells $13,060.32 in Stock
Revvity Goes Higher on Q3 Figures
Revvity to Hold Earnings Call on November 3, 2026
Revvity (NYSE:RVTY) Sets New 52-Week High - Here's Why
Revvity stock gains 5.2 percent ahead of the open
Revvity (NYSE:RVTY) Shares Up 5.2% - Time to Buy?

New MarketBeat Followers Over Time

Media Sentiment Over Time

Bio-Rad Laboratories stock logo

Bio-Rad Laboratories NYSE:BIO.B

$365.08 0.00 (0.00%)
As of 10/12/2026

Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Medpace stock logo

Medpace NASDAQ:MEDP

$609.89 -10.16 (-1.64%)
Closing price 04:00 PM Eastern
Extended Trading
$610.16 +0.26 (+0.04%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.

Mettler-Toledo International stock logo

Mettler-Toledo International NYSE:MTD

$1,597.59 +34.58 (+2.21%)
Closing price 03:59 PM Eastern
Extended Trading
$1,597.32 -0.28 (-0.02%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments. Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection equipment, x-ray systems, check weighing equipment, camera-based imaging equipment, track-and-trace solutions, and product inspection systems. The company's retail weighing solutions consist of weighing and software solutions, AI-driven image recognition solution, and automated packaging and labelling solutions for the meat backroom. It serves the life science industry, independent research organizations, and testing labs; food and beverage manufacturers; food retailers; chemical, specialty chemical, and cosmetics companies; food retailers; transportation and logistics, metals, and electronics industries; and the academic community through its direct sales force and indirect distribution channels. Mettler-Toledo International Inc. was incorporated in 1991 and is based in Columbus, Ohio.

Revvity stock logo

Revvity NYSE:RVTY

$155.08 -0.53 (-0.34%)
Closing price 03:59 PM Eastern
Extended Trading
$154.38 -0.70 (-0.45%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.